CXCR4 and acute myeloid leukemia: One blocks AML dissemination in different mouse models; however, it is associated with on-target and off-tumor toxicity in BM, showing a reduction in CXCR4+ granulocyte-monocyte progenitors and erythroblasts and a decrease in neutrophils and monocytes in the blood [40].